AU2001273327A1 - Method to enhance and/or prolong the effects of a primary challenge to a responsive system with a secondary challenge - Google Patents

Method to enhance and/or prolong the effects of a primary challenge to a responsive system with a secondary challenge

Info

Publication number
AU2001273327A1
AU2001273327A1 AU2001273327A AU7332701A AU2001273327A1 AU 2001273327 A1 AU2001273327 A1 AU 2001273327A1 AU 2001273327 A AU2001273327 A AU 2001273327A AU 7332701 A AU7332701 A AU 7332701A AU 2001273327 A1 AU2001273327 A1 AU 2001273327A1
Authority
AU
Australia
Prior art keywords
challenge
prolong
enhance
effects
responsive system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273327A
Inventor
Susan Baldwin
Mauricio Odio
Scott Edward Osborne
Bruce Ernest Tepper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU2001273327A1 publication Critical patent/AU2001273327A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/859—Waste, waste material, refuse or sludge, e.g. effluents, fecal matter

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
AU2001273327A 2000-07-12 2001-07-11 Method to enhance and/or prolong the effects of a primary challenge to a responsive system with a secondary challenge Abandoned AU2001273327A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/614,669 US6756032B1 (en) 2000-07-12 2000-07-12 Method to enhance and/or prolong the effects of a primary challenge to a responsive system with a secondary challenge
US09/614,669 2000-07-12
PCT/US2001/021758 WO2002004917A2 (en) 2000-07-12 2001-07-11 Method to enhance and/or prolong the effects of a primary challenge to a responsive system with a secondary challenge

Publications (1)

Publication Number Publication Date
AU2001273327A1 true AU2001273327A1 (en) 2002-01-21

Family

ID=24462242

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273327A Abandoned AU2001273327A1 (en) 2000-07-12 2001-07-11 Method to enhance and/or prolong the effects of a primary challenge to a responsive system with a secondary challenge

Country Status (3)

Country Link
US (1) US6756032B1 (en)
AU (1) AU2001273327A1 (en)
WO (1) WO2002004917A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US7066006B2 (en) * 2002-07-02 2006-06-27 Kimberly-Clark Worldwide, Inc. Method of collecting data relating to attributes of personal care articles and compositions
US7613619B1 (en) * 2004-03-30 2009-11-03 Harter Michael R Method for identifying allergens and other influencing agents that may cause a reaction
NZ618935A (en) 2010-08-04 2014-03-28 Karma Medical Prod Co Ltd Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
JP2014507481A (en) 2011-03-09 2014-03-27 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ Compositions and methods for colonic microbiota transplantation
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
US8962028B2 (en) 2012-10-18 2015-02-24 MiCal Pharmaceuticals LLC—H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limited Liability Company Topical steroid composition and method
CN107949391B (en) 2015-05-14 2021-11-09 克雷斯顿沃控股公司 Compositions for fecal flora transplantation and methods for making and using them and devices for delivering them
ES2909456T3 (en) 2015-05-22 2022-05-06 Univ Arizona State Methods to treat autism spectrum disorder and associated symptoms
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
US11433102B2 (en) 2017-04-05 2022-09-06 Finch Therapeutics Holdings Llc Compositions and methods for treating Parkinson's disease (PD) and related disorders
WO2018218159A1 (en) 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
CN111328284A (en) 2017-08-07 2020-06-23 芬奇治疗公司 Compositions and methods for maintaining and restoring a healthy intestinal barrier
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
AU2019351017A1 (en) 2018-09-27 2021-04-29 Finch Therapeutics Holdings Llc. Compositions and methods for treating epilepsy and related disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB636606A (en) 1946-11-08 1950-05-03 Nat Jewish Hospital At Denver Improvements in or relating to adhesive preparations for medical and like use and methods of obtaining the same
FR2735371B1 (en) 1995-06-19 1997-07-18 Cird Galderma METHOD FOR IDENTIFYING RAR RECEPTOR ANTAGONIST COMPOUNDS
FR2735370B1 (en) 1995-06-19 1997-07-18 Cird Galderma METHOD FOR IDENTIFYING AGONIST COMPOUNDS OF RXRS RECEPTORS
US5939046A (en) * 1996-05-17 1999-08-17 Halliday; Gary M. Method of evaluating an effect of a substance applied to the skin of a mammal
US5935581A (en) * 1996-07-24 1999-08-10 Kapadia; Govind J. Inhibitory effects of synthetic and natural colorants on carcinogenesis
SE513475C2 (en) 1996-11-22 2000-09-18 Peridoc Ab Hudsticktestkit
US6060612A (en) 1996-12-26 2000-05-09 Pacific Corporation Ceramide-like compounds and a method for preparation thereof, and a cosmetic composition containing the same
US6008007A (en) * 1997-01-31 1999-12-28 Oncotech, Inc. Radiation resistance assay for predicting treatment response and clinical outcome
US6074998A (en) 1998-01-26 2000-06-13 Lever Brothers Company Bar compositions comprising amphiphilic polyol ester structurant which releases oil
US6022896A (en) 1998-09-10 2000-02-08 Chesebrough-Pond's Usa Co. Petroselinic acid as an anti-irritant in compositions containing alpha-hydroxy acids

Also Published As

Publication number Publication date
WO2002004917A3 (en) 2003-01-09
WO2002004917A2 (en) 2002-01-17
US6756032B1 (en) 2004-06-29

Similar Documents

Publication Publication Date Title
AU2001273327A1 (en) Method to enhance and/or prolong the effects of a primary challenge to a responsive system with a secondary challenge
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
EP1333518A4 (en) Fuel cell system and method of operating the system
AU1969401A (en) System and method to compile instructions to manipulate linguistic structures into separate functions
AU2001253733A1 (en) Video-monitoring safety systems and methods
AU2001269847A1 (en) Lateral displacement pier and method of installing the same
AU2001253370A1 (en) Non-removable structural fastener assembly and method of forming same
AU2001234473A1 (en) Stabilized silica and methods of making and using the same
AU2001242573A1 (en) Mandibular advancer and method of installing the same
HK1038991A1 (en) Protection and control system of electricity system and construction method of the same
IL154688A0 (en) Hydrates of olanzapine and processes for the preparation thereof
AU2001252985A1 (en) Methods and devices to control polymerization
AU2001245288A1 (en) Overhanging form system and method of using the same
AU2002215014A1 (en) Method and device for the preparation of fuels
AU2002210482A1 (en) Secondary station and method of operating the station
AU2001253912A1 (en) Method of making aluminium oxynitride and aluminium oxynitride prepared by the method
AU3361201A (en) A transportable dam and a method of erecting the same
AU2001259196A1 (en) Structural protection device and method of installing the same
AU2001229393A1 (en) System and method to improve flotation systems
AU2002322611A1 (en) Method and system to determine revised dosage
AU2001263270A1 (en) Imaging-offset compensation methods and systems
GB0019360D0 (en) Method of combusting fuel
AU2001272798A1 (en) Method of reformatting web page and method of providing web page using the same
AU2002213057A1 (en) Method and system to construct action coordination profiles
AU2001288766A1 (en) Occupational safety system and method